Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.4650
+0.0040 (0.87%)
Last updated: May 14, 2026, 12:34 PM CET
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €8.35 million as of May 14, 2026. Its market cap has increased by 24.28% in one year.
Market Cap
8.35M
Enterprise Value
12.43M
Revenue
1.81M
Ranking
n/a
PE Ratio
1.52
Stock Price
€0.47
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 8.35M, an increase of 43.45%. That is a compound annual growth rate of 10.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 8.35M | 11.89% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.68M |
| GenSight Biologics | 20.40M |
| Aelis Farma | 17.13M |
| Poxel | 13.92M |
| Aton | 13.91M |
| Advicenne | 13.63M |
| NFL Biosciences | 12.19M |
| Plant Advanced Technologies | 7.57M |